BAFNAPHBSEBAFNA PHARMACEUTICALS LTDHighNeutral
Announced Tue, 11 Aug, 2026 · 17:50 IST

Q1 FY27 results approved: profit plunges; auditor flags GST demand

Revenue DeclineEmphasis Of MatterContingent Liabilities IncreasedResults View source PDFExplain this filing

BAFNAPH · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-2.0%Reaction day
₹273.75
prior close
—
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.4%-2.4% vs market

On the reaction day the stock moved 2.4 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs market
Reaction day
-2.0+0.4-2.4
Next day
-3.9+0.5-4.5
2d
-5.9+0.6-6.5
3d
-7.7+0.7-8.5
4d
-9.6+1.1-10.7
5d
-11.4+0.5-11.9
1w
-11.4+1.3-12.7
15d
+12.0+0.5+11.5
1m
+12.3-0.8+13.1
2m
+55.7-0.9+56.7
3m
———
UpDownMarket · Nifty Microcap 250Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board approved Q1 FY27 (June 2026) unaudited results. Revenue fell about 23% year-on-year to INR 2,658 lakhs. Profit after tax crashed from INR 339 lakhs to just INR 7.51 lakhs, with EPS at INR 0.03 versus INR 1.43. Auditor flagged GST demands totaling about INR 567 lakhs plus interest and penalty as an Emphasis of Matter. 31st AGM set for September 11, 2026 via video conferencing.

Likely market impact

Sharp profit drop and ongoing GST dispute are negatives; AGM and book closure dates noted for shareholders.